Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer ...

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making ...

Iptacopan targets one of the major proteins involved in the enzymes of the alternative pathway of complement, explains Carla ...

On-body delivery systems for subcutaneous isatuximab could enable patient self-administration, according to Xavier Leleu, MD, PhD, improving convenience and transforming treatment for ...

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...

Researchers sought to determine whether CD19-targeting CAR-T therapy would be an effective therapy for patients with relapsed/refractory LBCL.

Researchers sought to determine whether CAR-T therapy could improve HR-QoL scores for patients with relapsed or refractory multiple myeloma.

Washington State University and Mayo Clinic researchers have developed an electrochemical catheter hub that could someday ...